Hims & Hers Health Financial Statements
NYSE: HIMSHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Hims & Hers Health revenue and earnings
In fiscal 2025, Hims & Hers Health generated $2.35 billion in revenue, up 59.0% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $128.4 million (+1.8% year over year), for a net margin of 5.5% versus a median of -12.2% in the prior 5 years. Gross margin was 73.8% (down from 79.5%) and operating margin 4.5%.
Diluted earnings per share came in at $0.51, down from $0.53. Over the last 5 fiscal years, HIMS's revenue has grown at a 73.6% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Hims & Hers Health income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.35B | 1.48B | 872.00M | 526.92M | 271.88M | 148.76M | 82.56M |
| Revenue growth (YoY) | +59.00% | +69.33% | +65.49% | +93.81% | +82.77% | +80.18% | — |
| Cost of Revenue | 614.26M | 303.38M | 157.05M | 118.19M | 67.38M | 39.31M | 37.95M |
| Gross Profit | 1.73B | 1.17B | 714.95M | 408.72M | 204.49M | 109.45M | 44.60M |
| Operating Expenses | 1.63B | 1.11B | 744.40M | 477.42M | 319.54M | 124.59M | 119.02M |
| Selling, General & Admin | — | — | — | — | 183.63M | 65.61M | 55.86M |
| Operating Income | 105.61M | 61.90M | -29.45M | -68.70M | -115.04M | -15.14M | -74.41M |
| Interest Expense | — | — | — | — | 0 | 10.00K | 369.00K |
| Other Income (Expense) | 18.31M | 9.81M | 7.88M | 2.99M | 4.25M | -2.84M | 2.44M |
| Pretax Income | 123.92M | 71.71M | -21.57M | -65.71M | -110.80M | -17.99M | -71.97M |
| Income Tax | -4.44M | -54.33M | 1.98M | -31.00K | -3.14M | 127.00K | 90.00K |
| Net Income | 128.37M | 126.04M | -23.55M | -65.68M | -107.66M | -18.11M | -72.06M |
| Net Income growth (YoY) | +1.85% | — | — | — | — | — | — |
| EPS (Basic) | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 |
| EPS (Diluted) | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 |
| Shares Outstanding (Basic) | 224.96M | 215.94M | 209.34M | 204.52M | 186.78M | 35.35M | 34.76M |
| Shares Outstanding (Diluted) | 258.23M | 236.81M | 209.34M | 204.52M | 186.78M | 35.35M | 34.76M |
| EBITDA | 160.12M | 78.99M | -19.94M | -61.22M | -110.97M | -14.09M | -74.15M |
| Gross Margin | 73.84% | 79.45% | 81.99% | 77.57% | 75.22% | 73.58% | 54.03% |
| Operating Margin | 4.50% | 4.19% | -3.38% | -13.04% | -42.31% | -10.18% | -90.14% |
| Net Margin | 5.47% | 8.54% | -2.70% | -12.46% | -39.60% | -12.18% | -87.29% |
This table shows 7 annual periods of Hims & Hers Health's income statement, from FY 2025 back to FY 2019, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow HIMS's reporting calendar. What is a income statement?